Skip to main content
Gene therapy for long-term decrease of intraocular pressure

Gene therapy for long-term decrease of intraocular pressure

Unmet Need It is estimated that in the US alone, approximately 3 million individuals are living with glaucoma, making it the leading cause of blindness in the US. There currently is no cure for glaucoma,…

Read More

Gene therapy for Crb1 retinopathies

Gene therapy for Crb1 retinopathies

Value Proposition Current treatments for retinal disease include laser surgeries, injectable corticosteroids, and other medications which may slow the process of retinal degeneration but are not able to stop it. The Crb1 protein has been…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us